According to J&J, this approval offers a potential new standard of care (SOC) as early as second line and brings a novel ...

Swiss pharma Roche (ROG: SIX) reported positive Phase II results for its investigational amylin analog petrelintide, showing meaningful weight loss and a placebo-like tolerability profile in people ...

US drugmaker Vertex Pharmaceuticals today announced data from a Phase IV study of Journavx (suzetrigine), a prescription ...

Swedish specialty pharma Orexo is reorganizing its management team as it pivots away from direct US commercialization ...

The Accelerating Clinical Trials in the EU (ACT EU) initiative has published a draft guidance document outlining how clinical ...

Cambridge, USA-based precision allosteric therapeutics biotech Atavistik Bio has announced the closing of a $40 million ...

Shares of US clinical-stage biotech Tenaya Therapeutics closed up more than 40% at $0.82 yesterday following its announcement of a potentially lucrative collaboration.

Hangzhou Sciwind Biosciences, a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, today announced that China's National Medical ...

Seattle-based Nautilus Biotechnology, a specialist in single-molecule proteome analysis, has announced the appointment of Amber Faust as vice president of sales.

Servier, a French independent international pharmaceutical group governed by a foundation, today announced that it has entered into a definitive agreement to acquire Day One Biopharmaceuticals for $21 ...

Germany’s Merck KGaA reported broadly stable full-year 2025 results, with modest top-line pressure from currency headwinds ...

French pharma Sanofi (Euronext: SAN) has agreed to license the experimental drug rovadicitinib from China’s Sino Biop (HKEX: 1177), paying $135 million upfront for exclusive development and ...